Skip Navigation

Mark Pomerantz, MD

Medical Oncology

Make an Appointment
Watch Video


  • Physician
  • Assistant Professor of Medicine, Harvard Medical School


Clinical Interests

  • Genetics
  • Prostate cancer
  • Testicular cancer

Contact Information

  • Appointments877-332-4294 (new)
    617-582-9725 (follow-up)
  • Office Phone Number617-632-4524
  • Fax617-632-2165


Dr. Mark Pomerantz is a medical oncologist at the Dana-Farber Cancer Institute. Dr. Pomerantz received his undergraduate degree from Yale University and his medical degree from Stanford University. He trained in Internal Medicine at Brigham and Women's Hospital in Boston, Massachusetts. He then pursued a fellowship in Medical Oncology at the Dana-Farber Cancer Institute in Boston. Dr. Pomerantz received his post-doctroal training in cancer genetics with Dr. Matthew Freedman at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. He is on faculty at the Dana-Farber Cancer Institute in the Lank Center for Genitourinary Oncology.

Board Certification:

  • Internal Medicine, 2004
  • Medical Oncology, 2007


  • Dana-Farber/Partners CancerCare, Hematology/Oncology


  • Brigham and Women's Hospital, Internal Medicine

Medical School:

  • Stanford University School of Medicine


Inherited risk of cancer and genetic determinants disease outcome

Dr. Pomerantz's research focuses on the factors associated with cancer risk, with an emphasis on prostate cancer. Prostate cancer develops in the setting of many environmental and inherited risk factors. Since 2006, the inherited component of the disease has come into clearer focus. Multiple genetic markers, inherited from one's parents and highly associated with risk of prostate cancer, have been discovered. However, the mechanism in which these inherited factors predispose one to disease is unknown. Working closely with clinicians, biostatisticians and epidemiologists at Dana-Farber and the Broad Institute, he is actively deciphering this mechanism in an attempt to define the underpinnings of prostate cancer risk. 

Research Departments:


Dana-Farber Cancer Institute
450 Brookline Avenue
Dana 1230
Boston, MA 02215
Get Directions